Literature DB >> 27322955

Relationship between tumor-associated macrophage subsets and CD47 expression in squamous cell carcinoma of the head and neck in the tumor microenvironment.

Koichi Sakakura1, Hideyuki Takahashi1, Kyoichi Kaira2, Minoru Toyoda1, Takaaki Murata1, Hiroshi Ohnishi3, Tetsunari Oyama4, Kazuaki Chikamatsu1.   

Abstract

Tumor-associated macrophages (TAM) have been classified into an immunostimulatory M1 subset against microbes and malignancies, and an immunoregulatory M2 subset that secretes immunosuppressive cytokines in order to repair tissues damaged by malignancies. The infiltration of M2 in the tumor microenvironment is known to facilitate immunosuppression and tumor-promoting properties. In the present study, we investigated the phagocytic potential of these macrophage subsets in oral squamous cell carcinoma (OSCC) in relation to the expression of CD47, the 'don't eat me' signal against macrophages. The macrophage subsets M1 (induced by GM-CSF and IFN-γ) and M2 (induced by M-CSF and IL-10) were derived from the CD14(+) cells of healthy donors. Phagocytosis of the CFSE-labeled CD47(+) cell line HSC-3 by M1/M2 was assessed using flow cytometry and suppressed by an anti-CD47 neutralizing antibody or CD47 siRNA. Furthermore, CD68(+) and CD163(+) macrophage subset counts infiltrating tumor tissue and the expression of CD47 on cancer cells were examined immunohistochemically in 74 cases of OSCC, and their relationships with clinicopathological parameters or prognoses were determined. The phagocytic potential of M1 was similar to that of M2 in vitro. Phagocytosis by M1 increased in a CD47-dependent manner by the neutralizing antibody and siRNA, but did not in M2. An immunohistochemical (IHC) analysis revealed that the expression of CD47 did not correlate with macrophage subsets in peritumoral tissue or with any clinicopathological parameters; however, the stronger expression of CD47 by cancer cells and larger number of total macrophages/M2 were independently related to shorter survivals. Our results suggest that the expression of CD47 by cancer cells is related to evasion from phagocytosis, particularly that by M1 in vitro. IHC results indicate that various mechanisms are involved in the engulfing potential of TAM subsets in vivo.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27322955     DOI: 10.1038/labinvest.2016.70

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  40 in total

Review 1.  Macrophage plasticity and polarization: in vivo veritas.

Authors:  Antonio Sica; Alberto Mantovani
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

Review 2.  The CD47-SIRPα pathway in cancer immune evasion and potential therapeutic implications.

Authors:  Mark P Chao; Irving L Weissman; Ravindra Majeti
Journal:  Curr Opin Immunol       Date:  2012-02-04       Impact factor: 7.486

3.  Identification of a factor that links apoptotic cells to phagocytes.

Authors:  Rikinari Hanayama; Masato Tanaka; Keiko Miwa; Azusa Shinohara; Akihiro Iwamatsu; Shigekazu Nagata
Journal:  Nature       Date:  2002-05-09       Impact factor: 49.962

Review 4.  Functions and molecular mechanisms of the CD47-SIRPalpha signalling pathway.

Authors:  Takashi Matozaki; Yoji Murata; Hideki Okazawa; Hiroshi Ohnishi
Journal:  Trends Cell Biol       Date:  2009-01-12       Impact factor: 20.808

5.  CD4+ T helper responses in squamous cell carcinoma of the head and neck.

Authors:  Kazuaki Chikamatsu; Koichi Sakakura; Takanori Yamamoto; Nobuhiko Furuya; Theresa L Whiteside; Keisuke Masuyama
Journal:  Oral Oncol       Date:  2008-01-24       Impact factor: 5.337

6.  M2-polarized tumor-associated macrophages promoted epithelial-mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway.

Authors:  Chao-Ying Liu; Juan-Ying Xu; Xiao-Yan Shi; Wei Huang; Ting-Yan Ruan; Ping Xie; Jun-Li Ding
Journal:  Lab Invest       Date:  2013-06-10       Impact factor: 5.662

7.  Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas.

Authors:  Y Komohara; K Ohnishi; J Kuratsu; M Takeya
Journal:  J Pathol       Date:  2008-09       Impact factor: 7.996

8.  Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature.

Authors:  Qiong-wen Zhang; Lei Liu; Chang-yang Gong; Hua-shan Shi; Yun-hui Zeng; Xiao-ze Wang; Yu-wei Zhao; Yu-quan Wei
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

9.  Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones.

Authors:  D F Fiorentino; M W Bond; T R Mosmann
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

10.  Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: correlation of CD163 expression, cytokine levels and early relapse.

Authors:  Silke Reinartz; Tim Schumann; Florian Finkernagel; Annika Wortmann; Julia M Jansen; Wolfgang Meissner; Michael Krause; Anne-Marie Schwörer; Uwe Wagner; Sabine Müller-Brüsselbach; Rolf Müller
Journal:  Int J Cancer       Date:  2013-07-19       Impact factor: 7.396

View more
  23 in total

1.  Cyclin D1b induces changes in the macrophage phenotype resulting in promotion of tumor metastasis.

Authors:  Yuxue Wang; Yi Liu; Lei Xiang; Lintao Han; Xiaowei Yao; Yibing Hu; Fenghua Wu
Journal:  Exp Biol Med (Maywood)       Date:  2021-09-13

2.  Systemic immune responses are associated with molecular characteristics of circulating tumor cells in head and neck squamous cell carcinoma.

Authors:  Hiroe Tada; Yurino Nagata; Hideyuki Takahashi; Toshiyuki Matsuyama; Shota Ida; Ikko Mito; Kazuaki Chikamatsu
Journal:  Mol Clin Oncol       Date:  2021-05-26

Review 3.  RNA interference: new mechanistic and biochemical insights with application in oral cancer therapy.

Authors:  Smaranda Buduru; Alina-Andreea Zimta; Cristina Ciocan; Cornelia Braicu; Diana Dudea; Alexandra Iulia Irimie; Ioana Berindan-Neagoe
Journal:  Int J Nanomedicine       Date:  2018-06-08

4.  Active Role of the Necrotic Zone in Desensitization of Hypoxic Macrophages and Regulation of CSC-Fate: A hypothesis.

Authors:  Maryam Mehrabi; Fatemeh Amini; Shima Mehrabi
Journal:  Front Oncol       Date:  2018-06-25       Impact factor: 6.244

5.  SIRT1 inhibits hepatocellular carcinoma metastasis by promoting M1 macrophage polarization via NF-κB pathway.

Authors:  Bei Zhou; Yun Yang; Cuiping Li
Journal:  Onco Targets Ther       Date:  2019-04-04       Impact factor: 4.147

Review 6.  Targeting Cellular Metabolism Modulates Head and Neck Oncogenesis.

Authors:  Yi-Ta Hsieh; Yi-Fen Chen; Shu-Chun Lin; Kuo-Wei Chang; Wan-Chun Li
Journal:  Int J Mol Sci       Date:  2019-08-14       Impact factor: 5.923

7.  Tissue-infiltrating immune cells as prognostic markers in oral squamous cell carcinoma: a systematic review and meta-analysis.

Authors:  Elin Hadler-Olsen; Anna Maria Wirsing
Journal:  Br J Cancer       Date:  2019-02-27       Impact factor: 7.640

Review 8.  Engineering macrophages to phagocytose cancer cells by blocking the CD47/SIRPɑ axis.

Authors:  Hongcheng Yang; Ruoyang Shao; Hongxin Huang; Xinlong Wang; Zhili Rong; Ying Lin
Journal:  Cancer Med       Date:  2019-06-11       Impact factor: 4.452

9.  CD47 Overexpression Is Associated with Epstein-Barr Virus Infection and Poor Prognosis in Patients with Nasopharyngeal Carcinoma.

Authors:  Zhi-Hui Wang; Xiao-Feng Pei; Zhi-Quan Zhu; Zhong Lin; Yin-Yan Mao; Xiao-Lu Xu; You-Li Luo; Li Zhang; Pei-Jian Peng
Journal:  Onco Targets Ther       Date:  2020-04-21       Impact factor: 4.147

Review 10.  Targeting of CD163+ Macrophages in Inflammatory and Malignant Diseases.

Authors:  Maria K Skytthe; Jonas Heilskov Graversen; Søren K Moestrup
Journal:  Int J Mol Sci       Date:  2020-07-31       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.